ArticleRSC advances2022
Decreasing free fatty acid of crude palm oil with polyvinylidene fluoride hollow fiber membranes using a combination of chitosan and glutaraldehyde.
Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 13 citations in OpenAlex.
- Soybean molasses: a promising substrate for the production of microbial oil by Phaffia rhodozyma.Bioprocess and biosystems engineering · 2026Article
- Development of Chitosan Polymer Membranes with Potential Use in Filtration Processes.Membranes · 2026Article
- Article
- Performance of a membrane fabricated from high-density polyethylene waste for dye separation in water.RSC advances · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Crude palm oil (CPO) has emerged as a significant commodity in the economic and social development of producer nations. However, the presence of free fatty acids (FFAs) results in decreased CPO quality. Due to many advantages, the PVDF hollow fiber membrane has a higher potential to remove FFA from CPO than other polymeric membranes, despite the fact that FFA rejection performance remains poor. To solve this issue, membrane surface modification has emerged as one of the potential options for increasing electrostatic contact between the membrane surface and the FFA, resulting in high efficiency FFA separation from CPO. In this investigation, the membrane surface was coated with chitosan (CS) as a coating agent and glutaraldehyde (GA) as a crosslinking agent. The findings of the characterization demonstrated that the presence of a CS/GA combination with a low CS weight on the membrane surface resulted in enhanced hydrophilicity, porosity, water flow, and surface roughness. Furthermore, as compared to the uncoated PVDF hollow fiber membrane, the performance of the CPO with PVDF/CS 0.5 hollow fiber membrane achieved a maximum result of FFA rejection of up to 14.99%. The use of a mixture of CS and GA on the PVDF membrane surface to improve FFA reduction has been shown to be a promising technique for scaling up membrane technology.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.